DDD Group Plc. (DDDGY: OTC Link) | Director’s Dealing


Director’s Dealing

Jan 03, 2013

OTC Disclosure News Service

Los Angeles, CA

DDD Group plc (AIM: DDD; OTCQX: DDDGY), the 3D solutions company, confirms that the previously announced exercise request of Dr. Sanji Arisawa was completed effective 27 December 2012. Dr. Arisawa exercised options over 200,000 ordinary shares of 1p each in the Company (the “Ordinary Shares”) at an exercise price of 10p per share (together the “Option Exercise”). Following the Option Exercise, Dr. Arisawa’s interest in the Company stands at 1,889,200 Ordinary Shares or approximately 1.4% of the issued ordinary share capital and total voting rights in the Company. Dr. Arisawa is the Chairman of Arisawa Manufacturing Corporation Ltd. which currently owns 29,856,123 Ordinary Shares or 22.1% of the issued ordinary share capital and total voting rights.


Dr. Arisawa’s shares are part of the block admission that was announced on 12 June 2012 and admitted to AIM on 18 June 2012. 


For the purposes of Disclosure and Transparency Rules, following the Option Exercise the Company’s total issued and admitted share capital was 134,628,812 Ordinary Shares as at 31 December 2012. There are no Ordinary Shares held in treasury. The total number of voting rights in the Company will therefore be 134,628,812.


The above figure of 134,628,812 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.




The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Leave a Reply